India's drug controller clears Bharat Biotech's nasal vaccine against COVID-19 for emergency use
STORY: India's drug controller clears Bharat Biotech's nasal vaccine against COVID-19 for emergency use
DATELINE: Sept. 7, 2022
LENGTH: 00:01:31
LOCATION: New Delhi
CATEGORY: HEALTH
SHOTLIST:
1. various of of India gate
2. various of hospital area
3. various of vaccination centre
4. various of traffic
STORYLINE:
India's federal health minister Mansukh Mandaviya said on Tuesday the Central Drugs Standard Control Organisation (CDSCO) has cleared vaccine maker Bharat Biotech's nasal vaccine against COVID-19 for emergency use.
Mandaviya has described the development as a big boost to the ongoing fight against COVID-19.
"Big Boost to India's Fight Against COVID-19! Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by CDSCO for primary immunization against COVID-19 in 18 plus age group for restricted use in emergency situation," Mandaviya said in a brief statement posted on social media.
The health minister said the step would further stre
- Product Code
- ILEA001014357
- Registered date
- 2022/9/07 00:00:00
- Credit
- Xinhua / Kyodo News Images
- Media source
- Xinhua News Agency.All Rights Reserved
- Media size
- 1920 × 1080 pixel
- Deployment size
- 94.11(MB)*
*File size when opened in Photoshop, etc.